Ropes & Gray Represents Avista Capital Partners in its Acquisition of Taconic Biosciences

In The News
November 2, 2022

Ropes & Gray represented Avista Capital Partners in its acquisition of Taconic Biosciences, a provider of genetically engineered research models and related services, from H.I.G. Capital. Terms of the transaction were not disclosed. The announcement was made public on Nov. 1 in a press release.

Avista Capital, founded in 2005, is a leading New York-based private equity firm with over $8 billion invested in more than 40 growth-oriented healthcare businesses globally. Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services.

The Ropes & Gray team was led by private equity partner Bob Rivollier, and included senior private equity associate Sam Levitt, tax partner Benjamin Rogers, benefits partner Alexandra Alperovich, labor & employment partner Megan Bisk, finance partner Arek Maczka, real estate partner Peter Alpert, health care partner Devin Cohen, life sciences regulatory & compliance partners Kellie Combs and Lincoln Tsang, antitrust partner Annie Herdman and litigation & enforcement partner Brendan Hanifin.